title: Paediatric renal tumours: perspectives from the SIOP-RTSG.
abstract: The >90% rates of overall survival for children with Wilms tumour are remarkable and have been achieved at the same time as reducing treatment for most patients. However, beneath this headline figure, 20% of patients still relapse after first-line therapy and up to 25% of survivors report severe late effects. The aim of the SIOP-RTSG is to improve outcomes and to reduce acute and late treatment toxic effects in all children.
mesh_terms: D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D009396:Wilms Tumor / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*